Investing First patient dosed in Phase IIb imaging for Brain Mets by admin April 28, 2025 April 28, 2025 Radiopharm Theranostics (RAD:AU) has announced First patient dosed in Phase IIb imaging for Brain Mets Download the PDF here. This post appeared first on investingnews.com previous post Binding Commitments Received for A$1.0 Million under Convertible Note Placement next post RHI: Acqn of royalty over Sandstone Gold Project tenements You may also like Harvest Gold Identifies 15 Primary And 10 Secondary... June 13, 2025 Top 5 Canadian Nickel Stocks of 2025 August 1, 2025 4 Biggest Cybersecurity ETFs in 2025 April 29, 2025 Tech Weekly: Semiconductor Stocks Rally on Fed Rate... September 22, 2025 Corporate Funding Update September 3, 2025 US Antimony Wins US$245 Million Pentagon Deal to... September 24, 2025 Australia Awards Major Project Status to Donald Rare... October 22, 2025 QEM Appoints New CEO as It Secures $2.05M... May 29, 2025 Ericsson, Rogers Launch Canada’s First Underground 5G Network... June 21, 2025 Right to Earn Majority Interest in Highly Prospective... June 16, 2025